Posted by kinasepro on September 1, 2009
as always, being 18 months behind the times put you 6 months ahead of the curve.
Posted by kinasepro on August 13, 2009
Well.. maybe this compound will kill it: Polymorphic Forms / WO/2009/098612 & its from Pfizer no less –
Part Axitinib, part Birb, Part SGX… All MW: 700
Thanks for the email PN.
Posted by kinasepro on August 7, 2009
Posted by kinasepro on August 1, 2009
Posted by kinasepro on July 31, 2009
Its a salt form of ENMD-981693…
Posted by kinasepro on July 30, 2009
WO/2009/093972 reminds you of…
Posted by kinasepro on July 25, 2009
Posted by kinasepro on July 14, 2009
… A RAF candidate & Sunesis got a milestone,
In August 2004 the companies entered into a collaboration to discover and develop small molecule cancer therapeutics targeting kinases, a family of cell signaling enzymes that play a major role in the progression of cancer. The research term of this collaboration ended in June of 2008. Sunesis retains an option to participate in the co-development and co-promotion of the Raf kinase inhibitor resulting from this collaboration.